◼ Archived
Business
🔮 holds ✗
Teva autoimmune antibody notches ph. 2 win in celiac disease
Teva's experimental antibody TEV-408 meets its primary goal in a mid-stage celiac disease trial.
1 trends tracked about this subject — the full history, oldest to newest below.
Teva's experimental antibody TEV-408 meets its primary goal in a mid-stage celiac disease trial.